New Drugs for Targeted Radionuclide Therapy in Metastatic Prostate Cancer

The authors review various combinations of isotopes and vectors being used to target prostate cancer cells and optimize pharmacokinetics. Promising innovations include chemical modifications to improve biodistribution, identification of new targets, and the use of novel radioisotopes such as α emitters.